Abeona Therapeutics, Inc. (ABEO)
5.965
-0.02
(-0.25%)
USD |
NASDAQ |
Sep 02, 16:00
5.965
0.00 (0.00%)
After-Hours: 17:53
Abeona Therapeutics Research and Development Expense (TTM) : 23.37M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 23.37M |
| March 31, 2026 | 24.41M |
| December 31, 2025 | 24.80M |
| September 30, 2025 | 27.94M |
| June 30, 2025 | 33.28M |
| March 31, 2025 | 37.09M |
| December 31, 2024 | 34.36M |
| September 30, 2024 | 32.74M |
| June 30, 2024 | 30.95M |
| March 31, 2024 | 30.26M |
| December 31, 2023 | 31.09M |
| September 30, 2023 | 29.98M |
| June 30, 2023 | 28.33M |
| March 31, 2023 | 26.46M |
| December 31, 2022 | 28.96M |
| September 30, 2022 | 34.39M |
| June 30, 2022 | 36.88M |
| March 31, 2022 | 37.66M |
| December 31, 2021 | 34.32M |
| September 30, 2021 | 31.87M |
| June 30, 2021 | 31.86M |
| March 31, 2021 | 30.53M |
| December 31, 2020 | 30.14M |
| September 30, 2020 | 30.50M |
| June 30, 2020 | 33.45M |
| Date | Value |
|---|---|
| March 31, 2020 | 43.65M |
| December 31, 2019 | 48.57M |
| September 30, 2019 | 52.11M |
| June 30, 2019 | 49.11M |
| March 31, 2019 | 40.96M |
| September 30, 2018 | 34.93M |
| June 30, 2018 | 25.06M |
| March 31, 2018 | 22.95M |
| December 31, 2017 | 16.99M |
| September 30, 2017 | 14.32M |
| June 30, 2017 | 13.79M |
| March 31, 2017 | 11.00M |
| December 31, 2016 | 10.66M |
| September 30, 2016 | 9.689M |
| June 30, 2016 | 8.525M |
| March 31, 2016 | 6.117M |
| December 31, 2015 | 4.715M |
| September 30, 2015 | 2.679M |
| June 30, 2015 | 1.171M |
| March 31, 2015 | 0.642M |
| December 31, 2014 | 0.333M |
| September 30, 2014 | 0.426M |
| June 30, 2014 | 0.589M |
| March 31, 2014 | 0.705M |
| December 31, 2013 | 0.884M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Forum Markets, Inc. | -- |
| Corcept Therapeutics, Inc. | 253.86M |
| ACADIA Pharmaceuticals, Inc. | 331.01M |
| Alnylam Pharmaceuticals, Inc. | 1.509B |
| Anika Therapeutics, Inc. | 27.45M |